This 2025 study tested curcumin combined with omega-3. In rats with chemically induced joint damage, the combination by mouth reduced pain and conserved cartilage. In human osteoarthritic cartilage cells stimulated with IL-1 beta, it reduced MMP1, MMP3 and MMP13 messages and raised two markers of mitochondria.
Wistar rats were injected with monosodium iodoacetate to damage the joint, then given a vehicle, curcumin, curcumin with omega-3, or the anti-inflammatory drug celecoxib by mouth. Pain was measured by paw withdrawal and weight bearing, and cartilage damage by histology, the Mankin score and micro-CT. Separately, human chondrocytes from osteoarthritic cartilage, stimulated with interleukin-1 beta, were treated with curcumin and omega-3 and their catabolic markers measured.
The combination reduced pain and conserved cartilage in the rats. In the human cells, it reduced messenger RNA for MMP1, MMP3 and MMP13. It also raised two mitochondrial markers, cytochrome c oxidase 4 and TOMM20. The authors note there had been no earlier evidence of a combined effect of curcumin and omega-3.
The abstract gives no doses, durations or animal numbers. It reports the combination's results, so it does not tell us how much came from curcumin and how much from omega-3, and it does not report how curcumin alone compared. The human evidence comes from cells in a dish, measured as gene messages rather than enzyme activity.
It tests curcumin and omega-3 together and found MMP13 among the enzymes turned down in human cartilage cells. It also adds a mitochondrial angle: the combination raised markers of the cell's energy machinery, alongside its effect on the matrix-cutting enzymes.
In lab and animal studies, yes. Curcumin lowered MMP13 in rat cartilage cells exposed to IL-1 beta, and a curcumin metabolite bound and blocked MMP13 directly and...
Yes, in lab studies. The inflammatory messenger IL-1 raised MMP13 in human cartilage and cartilage cells in several studies, and TNF-alpha did too. To switch the MMP13...